呋塞米负荷试验在儿童急性肾损伤风险中的应用
本研究基于两项前瞻性观察研究,纳入273例高危急性肾损伤(AKI)PICU患儿(RAI≥8且uNGAL≥150 ng/ml),其中112例接受了呋塞米负荷试验(FST)。FST无反应者后续新发或持续严重AKI及肾脏替代治疗(RRT)比例显著更高,尿流率对上述结局有良好预测价值,且不依赖AKI分期。
要点
- 高危AKI患儿中FST使用不一致,仅41%接受FST。
- FST无反应者2天后新发或持续严重AKI风险达89%,RRT风险达43%。
- 尿流率对严重AKI和RRT有良好预测性能(AUROC 0.89和0.84)。
核心结论
- FST在高危AKI患儿中使用不一致,但对新发或持续严重AKI及RRT接收具有预后价值,且独立于AKI分期。
研究设计与样本
- 研究合并两项前瞻性观察性研究,纳入273例RAI≥8且uNGAL≥150 ng/ml的PICU患儿,比较FST组与非FST组、FST反应者与无反应者。
主要发现
- 112例(41%)接受FST,其中60例(54%)为无反应者;无反应者2天后新发或持续严重AKI发生率为89% vs 37%(P<0.001),RRT接收率为43% vs 8%(P<0.001)。
- 尿流率预测新发或持续严重AKI的AUROC为0.89(95%CI 0.82-0.95,P<0.001),最佳截断值<4 ml/kg/h(PPV 83%,NPV 82%)。
- 尿流率预测RRT接收的AUROC为0.84(95%CI 0.76-0.93,P<0.001),最佳截断值<1 ml/kg/h(PPV 68%,NPV 86%)。
- 在3期AKI患者中,尿流率预测RRT接收的测试特征相似。
关键数值与推荐
- FST定义为静脉给予呋塞米≥0.75 mg/kg;FST反应者定义为4小时内尿流率≥3 ml/kg/h。
- 高危AKI风险定义为RAI≥8且uNGAL≥150 ng/ml。
临床怎么用
- 对高危AKI患儿可考虑FST评估预后,尿流率<4 ml/kg/h提示新发或持续严重AKI风险高,<1 ml/kg/h提示RRT风险高。
局限性
- FST使用不一致可能引入选择偏倚;研究为观察性设计,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The furosemide stress test (FST) is used to assess urine flow rate (UFR) after a furosemide bolus. FST predicts severe acute kidney injury (AKI) and renal replacement therapy (RRT) receipt in adults, with limited data in pediatric intensive care unit (PICU) patients. We implemented AKI risk stratification using the renal angina index (RAI) with urine neutrophil gelatinase-associated lipocalin (uNGAL) to guide FST in high-risk children but have not evaluated outcomes. METHODS: We combined 2 prospective, observational studies of high AKI risk PICU patients (RAI+: ≥ 8, uNGAL+: ≥ 150 ng/ml). We compared patients who underwent FST (≥ 0.75 mg/kg i.v. furosemide) in the first week versus those who did not, and FST responders (≥ 3 ml/kg/h UFR over 4 hours) versus nonresponders. We examined UFR's predictive performance for new or persistent severe AKI or RRT receipt 2 days later. RESULTS: Of 273 RAI+/uNGAL+ patients, 112 (41%) underwent FST, 60 (54%) were nonresponders. FST patients had higher admission uNGAL and AKI stage. Nonresponders received FST earlier, had higher AKI stage, and higher incidence of new or persistent severe AKI (89% vs. 37%, P < 0.001) and RRT receipt (43% vs. 8%, P < 0.001) 2 days later. UFR predicted new or persistent severe AKI (area under the receiver operating curve [ROC; AUROC]: 0.89; 95% confidence interval [CI]: 0.82-0.95, P < 0.001) with optimal cutoff < 4 ml/kg/h (positive predictive value [PPV]: 83%, negative predictive value [NPV]: 82%), and RRT receipt (AUROC: 0.84; 95% CI: 0.76-0.93, P < 0.001]) with optimal cutoff < 1 ml/kg/h (PPV: 68%, NPV: 86%). UFR predicted RRT receipt in patients with stage 3 AKI with similar test characteristics. CONCLUSION: FST is used inconsistently in high AKI risk children but has prognostic utility for new or persistent severe AKI, including RRT receipt, independent of AKI stage.
引用
- Clover-Brown I, Ceschia G, Gist KM, et al. Furosemide Stress Test Use in Children at Risk for Acute Kidney Injury. Kidney Int Rep. 2025. PMID: 41426025. doi:10.1016/j.ekir.2025.09.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。